Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the coronary AngioPlasty Amlodipine REStenosis Study (CAPARES)
Bjørn Jørgensen, MD*,
Svein Simonsen, MD, PhD*,
Knut Endresen, MD, PhD*,
Kolbjørn Forfang, MD, PhD*,
Karleif Vatne, MD*,
James Hansen, MD ,
John Webb, MD ,
Christopher Buller, MD ,
Gilles Goulet, MD||,
Jan Erikssen, MD, PhD¶ and
Erik Thaulow, MD, PhD, FACC*
* Department of Cardiology, Rikshospitalet, University of Oslo, Oslo, Norway
Foothills Hospital, University of Calgary, Calgary, Canada
St. Paul Hospital, Vancouver, Canada
Hospital Saint-Luc, Montreal, Canada
|| Cardiology Research, Vancouver Hospital, Vancouver, Canada
¶ Sentralsykehuset i Akershus, Nordbyhagen, Norway

View larger version (17K):
[in a new window]
|
Figure 1 Cumulative distribution curves for MLD in the amlodipine (n = 236) and placebo (n = 215) groups (per-protocol group) before and immediately after PTCA and at four-month follow-up after PTCA.
|
|
|